Expansion of Germline Variants in Primary Hyperparathyroidism: Fumarate Hydratase Deficiency as a Cause of Parathyroid Adenomas

Endocrine Pathology · Published 2026-07-22 · DOI 10.1007/s12022-026-09928-w

Free full text

Authors (16)

Hussam Alkaissi, Elias Chuki, Yi Liu, James Welch, Lynn Bliss, Niharika Shah, Sunita K. Agarwal, William F. Simonds, Martha Quezado, Sanaz Sakiani, Thorkell Andresson, Karel Pacak, Naris Nilubol, Lee S. Weinstein, Christopher A. Febres-Aldana, Smita Jha

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Alkaissi, H., Chuki, E., Liu, Y., et al. (2026). Expansion of Germline Variants in Primary Hyperparathyroidism: Fumarate Hydratase Deficiency as a Cause of Parathyroid Adenomas. Endocrine Pathology. https://doi.org/10.1007/s12022-026-09928-w

Related articles

• A rare coexistence: Ollier disease and primary hyperparathyroidism—mere coincidence or expanding the spectrum of Ollier disease? · JBMR Plus · 2026 · Cites or is cited by this article
• Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology · Genetics in Medicine · 2015 · Cites or is cited by this article
• An Integrative RNA Spliceosomic Landscape of Pancreatic Neuroendocrine Tumors Identifies Clinically Relevant Molecular Subgroups · Endocrine Pathology · 2026 · Same journal
• A Cauda Equina Neuroendocrine Tumor with Tyrosine Hydroxylase Expression · Endocrine Pathology · 2026 · Same journal
• Histopathological and Molecular Characteristics of Pediatric Adrenocortical Tumors: where Do we Stand? · Endocrine Pathology · 2026 · Same journal
• Prognostic Features in Surgically Resected Well-Differentiated Pancreatic Neuroendocrine Tumors: an Analysis of 904 Patients with 7882 Person-Years of Follow-Up · Endocrine Pathology · 2025 · Same journal
• Phenotypic Landscape of Pulmonary Neuroendocrine Tumors: Subtyped by OTP/ASCL1 Expression Correlated with Histology, Hormones and Outcome · Endocrine Pathology · 2025 · Same journal
• Recipient of the 2025 Endocrine Pathology Society Lifetime Achievement Award: Dr. Arthur S. Tischler, M.D. · Endocrine Pathology · 2025 · Same journal
• Multi-center Assessment of DLL3 Expression by Immunohistochemistry in Medullary Thyroid Carcinoma · Endocrine Pathology · 2025 · Same journal
• Clinicopathologic and Molecular Features of Poorly Differentiated Thyroid Carcinomas in Adults ≤ 45 Years of Age · Endocrine Pathology · 2026 · Same journal